| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |